HPV-DeepSeek, a liquid biopsy test combining whole genome sequencing and machine learning technology, has been reported to accurately identify head and neck cancers caused by the human papilloma virus (HPV) up to 10 years before symptoms appear. Results published in the Journal of the National Cancer Institute showcase the potential of this test to enable earlier detection and treatment of a form of cancer that is often diagnosed years after onset.

“Our study shows for the first time that we can accurately detect HPV-associated cancers in asymptomatic individuals many years before they are ever diagnosed with cancer,” said lead study author Daniel L. Faden, MD, head and neck surgical oncologist at Harvard Medical School and principal investigator in the Mike Toth Head and Neck Can

See Full Page